William Gassen
CIK: 0001954883
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Oscar Health Analyst Target Rises to $34.19. Analysts raised the consensus price target for Oscar Health by 12.09% to $34.19. This adjustment follows recent updates to the company's earnings roadmap and new product initiatives. The stock is currently trading near the upper end of its 52-week range, reflecting renewed interest in its growth prospects.
Transaction History
| HQY | ▲ Buy | Grant | 2,877 | $0 | 6/25/2026 | View on chart |
| OSCR | ▲ Buy | Grant | 8,475 | $0 | 6/4/2026 | View on chart |
| OSCR | ▲ Buy | Grant | 14,134 | $0 | 6/4/2025 | View on chart |
| OSCR | ▲ Buy | Grant | 8,974 | $0 | 6/6/2024 | View on chart |
| OSCR | ▲ Buy | Grant | 19,751 | $0 | 6/8/2023 | View on chart |
| OSCR | ▲ Buy | Grant | 31,506 | $0 | 12/7/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
HealthEquity Appoints Moody's CFO to Board Amid AI Cash Concerns
HealthEquity has appointed Noémie Heuland, CFO of Moody's, to its board of directors. This governance move comes as market commentary highlights concerns regarding the company's cash position in the context of AI adoption. The stock is currently trading near its 52-week low, with an average analyst target price of $119.33.
HealthEquity Appoints Moody's CFO to Board Amid AI Cash Concerns. HealthEquity has appointed Noémie Heuland, CFO of Moody's, to its board of directors. This governance move comes as market commentary highlights concerns regarding the company's cash position in the context of AI adoption. The stock is currently trading near its 52-week low, with an average analyst target price of $119.33.